Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
Therapeutic Category
Asthma, General and OTC medicines, Pulmonary, Respiratory
Dosage Form
Respule
Packaging Type
Sachets
Packaging
4*5*2ml
Price
₹300/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Buditerm L Respule is a combination of Levosalbutamol (1.25mg) and Budesonide (0.5mg) designed for use in the treatment and management of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. Levosalbutamol, a selective beta-2 agonist, acts as a bronchodilator, helping to relax the muscles in the airways and improve airflow. Budesonide, a corticosteroid, reduces inflammation and swelling in the airways, helping to prevent asthma attacks and COPD flare-ups.
This dual-action formulation provides both immediate relief from bronchoconstriction (due to Levosalbutamol) and long-term control by reducing airway inflammation (due to Budesonide). It is typically administered through a nebulizer, delivering the active ingredients directly to the lungs for maximum efficacy. Buditerm L Respule is used for both the acute relief of bronchospasm and as a maintenance therapy to prevent symptoms and reduce the frequency of flare-ups.
It is particularly effective for patients with moderate to severe asthma or COPD who need a combination of a bronchodilator and anti-inflammatory treatment to manage their condition. This medication helps control asthma symptoms such as wheezing, shortness of breath, and tightness in the chest, as well as reduce the frequency of exacerbations.
Possible side effects include throat irritation, hoarseness, dry mouth, headache, and a cough. In rare cases, tremors or palpitations may occur.
Indicated for the treatment of asthma and COPD, helping to relieve bronchospasm and reduce airway inflammation.
Consult your doctor if you have a history of cardiovascular diseases, infections, or tuberculosis before use.
Store in a cool, dry place away from direct sunlight and moisture. Keep out of the reach of children.
Composition : Levosalbutamol (1.25mg) + Ipratropium (500mcg)
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Salmeterol (25mcg) + Fluticasone Propionate (500mcg)
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Salmeterol (50mcg) + Fluticasone Propionate (250mcg)
Composition : Fluticasone Propionate 250mcg + Formoterol Fumarate 6mcg Life Cap
Composition : Salmeterol (50mcg) + Fluticasone Propionate (500 mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Fluticasone Propionate 500mcg + Formoterol Fumarate 12mcg Life Cap
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination respule is used for asthma, COPD, bronchospasm, wheezing, and acute or chronic respiratory airway inflammation. Levosalbutamol provides bronchodilation while budesonide reduces inflammation, making it a strong respiratory and nebulization therapy segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong and continuous demand in hospitals, emergency rooms, ICUs, pediatric clinics, and respiratory care centers. It is widely used in nebulization therapy for quick relief and long-term control of asthma and COPD, ensuring stable institutional and retail sales.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory and nebulization formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from hospital procurement, ICU demand, chronic respiratory disease management, specialist prescriptions, and repeat usage when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this nebulization combination can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.